Yüklüyor......
Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants
OBJECTIVE: Report clinical response to recombinant factor VIIa in a cohort of critically ill infants. STUDY DESIGN: We identified all infants who received factor VIIa in the Duke Neonatal Intensive Care Unit between January 2005 and July 2008. Hematologic data and volume of blood transfusions before...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2972386/ https://ncbi.nlm.nih.gov/pubmed/20671714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jp.2010.85 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|